Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
An Engineered Nanoimmunotherapy for Treating Neuroblastoma |
George Washington University / Rohan Fernandes, PhD |
'A' Award Grants |
2016 |
District of Columbia |
Epigenetic regulation of self-renewal pathways in hematopoietic and leukemic stem cells |
George Washington University / Alexandros Tzatsos, MD/PhD |
Young Investigator Grants |
2012 |
District of Columbia |
Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer |
Boston University / Kristin Long, PhD |
Psychosocial Grants |
2014 |
Massachusetts |
Blocking the Evil Messenger in MYCN-driven High-risk Neuroblastoma |
Boston University / Hui Feng, Md, PhD |
Innovation Grants |
2022 |
Massachusetts |
Pediatric Oncology Nurses' Experiences with Prognosis-Related Communication |
Marquette University / Amy Newman, RN, MSN |
Nurse Researcher Grants |
2014 |
Wisconsin |
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma |
University of Virginia, School of Medicine / John Bushweller, PhD |
Innovation Grants |
2015 |
Virginia |
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma |
University of Virginia, School of Medicine / Michael Engel, MD/PhD |
Reach Grants |
2016 |
Virginia |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP) |
Innovation Grants |
2015 |
Virginia |
Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified |
Broad Institute / Rameen Beroukhim, MD,PhD |
Innovation Grants |
2015 |
Massachusetts |